COVID-19 Thales Thermography Triage : Thermal Camera Feasibility Study
NCT ID: NCT04397380
Last Updated: 2020-05-22
Study Results
The study team has not published outcome measurements, participant flow, or safety data for this trial yet. Check back later for updates.
Basic Information
Get a concise snapshot of the trial, including recruitment status, study phase, enrollment targets, and key timeline milestones.
UNKNOWN
100 participants
OBSERVATIONAL
2020-05-20
2020-07-01
Brief Summary
Review the sponsor-provided synopsis that highlights what the study is about and why it is being conducted.
The aims of the feasibility study are to:
* Understand the acceptability of introducing the intervention within the Emergency Department setting
* Establish indicative patient recruitment numbers per week
* Determine the likely proportion of patients recruited from this group who have a high temperature
* Provide preliminary evidence that the technology can identify a high temperature in this diverse group of patients
* Provide preliminary data for machine learning training to support classification of patients as being with or without fever
The feasibility study will then inform the design and size of larger study to further develop and validate the the thermal imaging screening test to provide a 'with/ without' fever result.
Related Clinical Trials
Explore similar clinical trials based on study characteristics and research focus.
Thales Thermography Triage (3T) - Pilot Project
NCT04792450
Evaluation of Infrared Cameras and Non-contact Infrared Thermometers for Measuring Body Temperatures
NCT04370743
Continuous Temperature Monitoring for tHe Early Recognition of Febrile Neutropenia in Haematological MALignancies
NCT05203809
Clinical Accuracy and Reliability of Infrared Tympanic Thermometer in an Adult Emergency Department
NCT02937129
Fever Tracking Study
NCT05475067
Detailed Description
Dive into the extended narrative that explains the scientific background, objectives, and procedures in greater depth.
COVID-19 \[SARS-COV-2\] has placed a huge challenge on the world. In response to the crisis, Thales is engaged in a number of initiatives, including one aimed at the possible application of thermal imaging cameras to detect people with a fever and hence those who may be suffering from COVID-19. This initiative has received encouraging feedback from prospective users around the world who are looking, not only at the immediate issue in the hospitals, but also forward to a time beyond the current lockdowns, when cost effective techniques for surveying groups of people for potential COVID-19 sufferers will be required. This surveillance, for example, could be in hospitals, at airport gates, in buildings or outside in streets. As part of the initiative Thales Glasgow has been performing analysis and experiments using cameras looking at faces to confirm what temperature differences can be measured.
What Thales lacks is real world thermal images of patients suffering fever and access to clinicians who can advise on the medical aspects of the work. This research would fill these two voids.
Benefit and Rationale Existing thermal camera based fever detection systems suffer from two main issues that restrict their current application: Cost and Sensitivity.In order to achieve the required sensitivity, existing systems often require Black Body (BB) calibration sources to be visible in the scene. These BB sources are often more expensive than the cameras (circa one to two orders of magnitude more expensive). Thales believe they can achieve the required sensitivity without the need for BB sources by using advanced thermal camera correction algorithms.
The variability in skin emissivity makes conversions from irradiance as measured by a thermal camera, to absolute skin temperature inaccurate. Previous work place the emissivity of human skin between 0.990 and 0.999, however earlier research suggests that the value is 0.971 ± 0.005(SD). Typically in existing systems, this inaccurate, absolute temperature is used along with a simple threshold algorithm to find skin above a certain temperature leading to both false positives and false negatives.
Significant statistical correlation between the temperature of multiple facial features and measured human temperature has been observed. Their research found that for most facial features there was a correlation between multiple aspects of the facial view and recorded oral and tympanic temperature, with correlations of 0.5 or greater observed for multiple aspects of both the front and side of the face, with the ear offering the greatest statistical correlation.
Conditions
See the medical conditions and disease areas that this research is targeting or investigating.
Study Design
Understand how the trial is structured, including allocation methods, masking strategies, primary purpose, and other design elements.
COHORT
PROSPECTIVE
Study Groups
Review each arm or cohort in the study, along with the interventions and objectives associated with them.
ED Patients
Patients Presenting in Emergency Department
Thermography
Measure Temperature using Thermal Camera
Tympanic Temperature
Measure Temperature using Tympanic Temperature
Interventions
Learn about the drugs, procedures, or behavioral strategies being tested and how they are applied within this trial.
Thermography
Measure Temperature using Thermal Camera
Tympanic Temperature
Measure Temperature using Tympanic Temperature
Eligibility Criteria
Check the participation requirements, including inclusion and exclusion rules, age limits, and whether healthy volunteers are accepted.
Inclusion Criteria
* Patients able to read and understand English
* Patients able to give informed consent
* Patients being triaged through ED for any complaint (not necessarily COVID-19)
* Patients who do not have capacity to consent
* Patients attending ED who are fast-tracked without triage
16 Years
ALL
No
Sponsors
Meet the organizations funding or collaborating on the study and learn about their roles.
NHS Greater Clyde and Glasgow
OTHER
Responsible Party
Identify the individual or organization who holds primary responsibility for the study information submitted to regulators.
David Lowe
Dr David J Lowe
Principal Investigators
Learn about the lead researchers overseeing the trial and their institutional affiliations.
David J Lowe, MBChB
Role: PRINCIPAL_INVESTIGATOR
NHS Greater Glasgow and Clyde
Locations
Explore where the study is taking place and check the recruitment status at each participating site.
Queen Elizabeth University Hospital
Glasgow, , United Kingdom
Countries
Review the countries where the study has at least one active or historical site.
Central Contacts
Reach out to these primary contacts for questions about participation or study logistics.
Facility Contacts
Find local site contact details for specific facilities participating in the trial.
David J Lowe, MBChB
Role: primary
Other Identifiers
Review additional registry numbers or institutional identifiers associated with this trial.
INGC20AE209
Identifier Type: -
Identifier Source: org_study_id
More Related Trials
Additional clinical trials that may be relevant based on similarity analysis.